1. Home
  2. DERM vs GHI Comparison

DERM vs GHI Comparison

Compare DERM & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DERM
  • GHI
  • Stock Information
  • Founded
  • DERM 2014
  • GHI 1998
  • Country
  • DERM United States
  • GHI United States
  • Employees
  • DERM N/A
  • GHI N/A
  • Industry
  • DERM Biotechnology: Pharmaceutical Preparations
  • GHI Finance: Consumer Services
  • Sector
  • DERM Health Care
  • GHI Finance
  • Exchange
  • DERM Nasdaq
  • GHI Nasdaq
  • Market Cap
  • DERM 213.6M
  • GHI 254.1M
  • IPO Year
  • DERM 2021
  • GHI N/A
  • Fundamental
  • Price
  • DERM $7.92
  • GHI $6.44
  • Analyst Decision
  • DERM Strong Buy
  • GHI Strong Buy
  • Analyst Count
  • DERM 3
  • GHI 4
  • Target Price
  • DERM $12.67
  • GHI $13.00
  • AVG Volume (30 Days)
  • DERM 256.5K
  • GHI 163.3K
  • Earning Date
  • DERM 11-12-2025
  • GHI 11-06-2025
  • Dividend Yield
  • DERM N/A
  • GHI 22.66%
  • EPS Growth
  • DERM N/A
  • GHI N/A
  • EPS
  • DERM N/A
  • GHI 0.17
  • Revenue
  • DERM $59,399,000.00
  • GHI $26,247,399.00
  • Revenue This Year
  • DERM $26.16
  • GHI $209.99
  • Revenue Next Year
  • DERM $45.27
  • GHI $5.36
  • P/E Ratio
  • DERM N/A
  • GHI $38.71
  • Revenue Growth
  • DERM 2.82
  • GHI N/A
  • 52 Week Low
  • DERM $3.54
  • GHI $6.31
  • 52 Week High
  • DERM $9.40
  • GHI $13.29
  • Technical
  • Relative Strength Index (RSI)
  • DERM 48.07
  • GHI 10.94
  • Support Level
  • DERM $7.42
  • GHI $6.76
  • Resistance Level
  • DERM $9.40
  • GHI $8.72
  • Average True Range (ATR)
  • DERM 0.54
  • GHI 0.32
  • MACD
  • DERM -0.14
  • GHI -0.08
  • Stochastic Oscillator
  • DERM 27.53
  • GHI 9.25

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.

Share on Social Networks: